The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pandemic has posed a
huge threat to global health because of its rapid spread and various mutant variants. Critical …

Objectives To assess the effectiveness of influenza vaccine in immunosuppressed adults
with malignancies. The primary review outcome is all‐cause mortality, preferably at the end …

Objective To provide guidance to rheumatology providers on the use of coronavirus disease
2019 (COVID‐19) vaccines for patients with rheumatic and musculoskeletal diseases …

Background & Aims Two SARS-CoV-2 mRNA vaccines were approved to prevent COVID-19
infection, with reported vaccine efficacy of 95%. Liver transplant (LT) recipients are at risk of …

An international panel of experts prepared an evidenced-based guideline for vaccination of
immunocompromised adults and children. These guidelines are intended for use by primary …

Recently published studies have found an impaired immune response after SARS‐CoV‐2
vaccination in solid organ recipients. However, most of these studies have not assessed …

5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients |
Clinical Infectious Diseases | Oxford Academic Skip to Main Content Advertisement Oxford …

Background The annual standard-dose (SD) influenza vaccine has suboptimal
immunogenicity in solid organ transplant recipients (SOTRs). Influenza vaccine that contains …

Lung transplant recipients are given immunosuppressive therapy that might impair their
ability to generate an adequate immune response to the BNT162b2 vaccine. 1 However …

Patients undergoing solid-organ transplantation (SOT) or allogeneic hematopoietic cell
transplantation (HCT) are at increased risk for infectious complications. Community-acquired …